Insights on the Veterinary Medicine Global Market to 2027 – by Product, Animal Type, Route of Administration, Distribution Channel and Region – Yahoo…

Posted: July 19, 2022 at 2:11 am

DUBLIN, July 15, 2022 /PRNewswire/ --The "Veterinary Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global veterinary medicine market reached a value of US$ 31.06 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 48.58 Billion by 2027, exhibiting a CAGR of 7.74% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Veterinary medicine is a branch of science that deals in the prevention, control, diagnosis, and treatment of diseases that affect the health of domestic and wild animals. It helps maintain the health of food-producing animals, inhibit the transmission of zoonotic diseases from animal species to humans, and ensure a safe supply of food worldwide. At present, the escalating consumption of animal-derived products is increasing the adoption of veterinary medicines to monitor the health of agricultural animals and prevent human exposure to diseases.

The growing trend of nuclear families and inflating income levels have increased the overall spending of individuals on pets globally. This, in confluence with the rising concerns among pet parents about the well-being of their pets, represents one of the major factors supporting the demand for veterinary medicines.

The increasing penetration of pet insurance is further influencing the market growth. Apart from this, the expanding animal husbandry activities, along with the escalating cases of zoonotic and chronic diseases among animals, are increasing the concerns about food safety. This, along with the increasing number of commercial animal-production programs, is promoting the adoption of veterinary medicines for better diagnosis and treatment for livestock.

Moreover, the easy availability of advanced diagnostic imaging, novel therapies, nuclear and regenerative medicines, laser diagnostics, and specialized surgeries in numerous vet hospitals and clinics is bolstering the market growth. Furthermore, biomedical researchers are developing safe and effective vaccines to prevent pet diseases, which is anticipated to strengthen the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Archer-Daniels-Midland Company, Boehringer Ingelheim GmbH, Cargill Incorporated, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Merck & Co. Inc., Neogen Corporation, Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

How has the global veterinary medicine market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global veterinary medicine market?

What are the key regional markets?

What is the breakup of the market based on the product?

What is the breakup of the market based on the animal type?

What is the breakup of the market based on the route of administration?

What is the breakup of the market based on the distribution channel?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global veterinary medicine market and who are the key players?

What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction4.1 Overview4.2 Key Industry Trends

5 Global Veterinary Medicine Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast

6 Market Breakup by Product6.1 Drugs6.1.1 Market Trends6.1.2 Key Segments6.1.2.1 Anti-infective6.1.2.2 Anti-inflammatory6.1.2.3 Parasiticide6.1.3 Market Forecast6.2 Vaccines6.2.1 Market Trends6.2.2 Key Segments6.2.2.1 Inactivated Vaccines6.2.2.2 Attenuated Vaccines6.2.2.3 Recombinant Vaccines6.2.3 Market Forecast6.3 Medicated Feed Additives6.3.1 Market Trends6.3.2 Key Segments6.3.2.1 Amino Acids6.3.2.2 Antibiotics6.3.3 Market Forecast

7 Market Breakup by Animal Type7.1 Production7.1.1 Market Trends7.1.2 Market Forecast7.2 Companion7.2.1 Market Trends7.2.2 Market Forecast

8 Market Breakup by Route of Administration8.1 Oral8.1.1 Market Trends8.1.2 Market Forecast8.2 Parenteral8.2.1 Market Trends8.2.2 Market Forecast8.3 Topical8.3.1 Market Trends8.3.2 Market Forecast

9 Market Breakup by Distribution Channel9.1 Veterinary Hospitals and Clinics9.1.1 Market Trends9.1.2 Market Forecast9.2 Point-of-Care Testing/In-house Testing9.2.1 Market Trends9.2.2 Market Forecast9.3 Others9.3.1 Market Trends9.3.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape15.1 Market Structure15.2 Key Players15.3 Profiles of Key Players15.3.1 Archer-Daniels-Midland Company15.3.1.1 Company Overview15.3.1.2 Product Portfolio15.3.1.3 Financials15.3.1.4 SWOT Analysis15.3.2 Boehringer Ingelheim GmbH15.3.2.1 Company Overview15.3.2.2 Product Portfolio15.3.3 Cargill Incorporated15.3.3.1 Company Overview15.3.3.2 Product Portfolio15.3.3.3 SWOT Analysis15.3.4 Ceva Sante Animale15.3.4.1 Company Overview15.3.4.2 Product Portfolio15.3.5 Dechra Pharmaceuticals PLC15.3.5.1 Company Overview15.3.5.2 Product Portfolio15.3.5.3 Financials15.3.6 Elanco Animal Health Incorporated15.3.6.1 Company Overview15.3.6.2 Product Portfolio15.3.6.3 Financials15.3.7 Evonik Industries AG15.3.7.1 Company Overview15.3.7.2 Product Portfolio15.3.7.3 Financials15.3.8 Merck & Co. Inc. 15.3.8.1 Company Overview15.3.8.2 Product Portfolio15.3.8.3 Financials15.3.9 Neogen Corporation15.3.9.1 Company Overview15.3.9.2 Product Portfolio15.3.9.3 Financials15.3.9.4 SWOT Analysis15.3.10 Vetoquinol S.A.15.3.10.1 Company Overview15.3.10.2 Product Portfolio15.3.10.3 Financials15.3.11 Virbac15.3.11.1 Company Overview15.3.11.2 Product Portfolio15.3.11.3 Financials15.3.11.4 SWOT Analysis15.3.12 Zoetis Inc.15.3.12.1 Company Overview15.3.12.2 Product Portfolio15.3.12.3 Financials15.3.12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/kpoq5l

Media Contact:

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

View original content:https://www.prnewswire.com/news-releases/insights-on-the-veterinary-medicine-global-market-to-2027---by-product-animal-type-route-of-administration-distribution-channel-and-region-301587584.html

SOURCE Research and Markets

Go here to read the rest:
Insights on the Veterinary Medicine Global Market to 2027 - by Product, Animal Type, Route of Administration, Distribution Channel and Region - Yahoo...

Related Posts